Merck & Co., Inc. Deferred Income Taxes and Other Liabilities, Noncurrent
Merck & Co., Inc. (MRK) had Deferred Income Taxes and Other Liabilities, Noncurrent of $15.55 billion as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes
us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent · last filed 2013-11-07
- 2013-09-30: Deferred Income Taxes and Other Liabilities, Noncurrent $15.55B.
- 2013-06-30: Deferred Income Taxes and Other Liabilities, Noncurrent $15.84B.
- 2013-03-31: Deferred Income Taxes and Other Liabilities, Noncurrent $15.70B.
- 2012-12-31: Deferred Income Taxes and Other Liabilities, Noncurrent $16.07B.
| Period end | Deferred Income Taxes and Other Liabilities, Noncurrent |
|---|---|
| 2013-09-30 | $15.55B 10-Q · filed 2013-11-07 |
| 2013-06-30 | $15.84B 10-Q · filed 2013-08-07 |
| 2013-03-31 | $15.70B 10-Q · filed 2013-05-09 |
| 2012-12-31 | $16.07B 10-Q · filed 2013-11-07 |
| 2012-09-30 | $14.94B 10-Q · filed 2012-11-09 |
| 2012-06-30 | $15.88B 10-Q · filed 2012-08-07 |
| 2012-03-31 | $16.39B 10-Q · filed 2012-05-08 |
| 2011-12-31 | $16.41B 10-K · filed 2013-02-28 |
| 2011-09-30 | $16.65B 10-Q · filed 2011-11-08 |
| 2011-06-30 | $16.73B 10-Q · filed 2011-08-08 |
| 2010-12-31 | $17.85B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |